Abeona therapeutics announces presentations at the 27th european society of gene and cell therapy (esgct) congress

Abeona therapeutics inc. announced the presentations of data from the transpher a study, the company’s ongoing phase 1/2 clinical trial evaluating abo-102 for the treatment of sanfilippo syndrome type a (mps iiia), and research updates from its library of novel aimtm adeno-associated virus (aav) capsids at the 27th european society of gene and cell therapy (esgct) congress, to be held october 22-25, 2019 in barcelona, spain.
ABEO Ratings Summary
ABEO Quant Ranking